Radiochemotherapy after transurethral resection is an effective treatment method in T1G3 bladder cancer

Anticancer Research

Volumn 25, Issue 3 A, 2005, Pages 1623-1628

  Akçetin, Ziya ^a,b   Todorov, J ^a   Tuzel E ^a   Engehausen, D G ^a   Krause, F S ^a   Sauer, R ^a   Schrott, K M ^a   Rodel C ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Bladder cancer; Radiochemotherapy; Transurethral resection

Indexed keywords

CARBOPLATIN; CISPLATIN; FLUOROURACIL;

ADULT; AGED; ANEMIA; BLADDER CANCER; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURGERY; CONFERENCE PAPER; CYSTECTOMY; DIARRHEA; DISEASE COURSE; DYSURIA; FEMALE; FOLLOW UP; HUMAN; INTESTINE OBSTRUCTION; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; THROMBOCYTOPENIA; TRANSURETHRAL RESECTION; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 21244502183     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (27)

1. Soloway MS, Sofer M and Vaidya A: Contemporary management of stage T1 transitional cell carcinoma of the bladder. J Urol 167: 1573-83, 2002.
2. Cookson MS and Sarosdy MF: Management of stage T1 superficial bladder cancer with intravesical bacillus Calmette-Guerin. J Urol 148: 797-801, 1992.
3. Hurle R, Losa A, Manzetti A et al: Intravesical bacillus Calmette-Guerin in stage T1 grade 3 bladder cancer therapy: a 7 year follow-up. Urology 54: 258-263, 1999.
4. Peyromaure M, Guerin F, Amsellem-Quazana D et al: Intravesical bacillus Calmette-Guerin therapy for stage T1 grade 3 transitional cell carcinoma of the bladder: recurrence, progression and survival in a study of 57 patients. J Urol 169: 2110-2112, 2003.
5. Amling CL, Thrasher JB, Frazier HA et al: Radical cystectomy for stages Ta, Tis and T1 transitional cell carcinoma of the bladder. J Urol 151: 31-36, 1994.
6. Freeman JA, Esrig D, Stein JP et al: Radical cystectomy for high-risk patients with superficial bladder cancer in the era of orthotopic urinary reconstruction. Cancer 76: 833-839, 1995.
7. Stockle M, Alken P, Engelmann U et al: Radical cystectomy-often too late? Eur Urol 13: 361-367, 1987.
8. Shipley WU, Kaufman DS, Zehr E et al: Selective bladder preservation by combined modality protocol treatment: long-term follow-up of 190 patients with invasive bladder cancer. Urology 60: 62-68, 2002.
9. Rodel C, Grabenbauer GG, Kuhn R et al: Combined modality treatment and selective organ preservation in invasive bladder cancer: long term results. J Clin Oncol 20: 3061-71, 2002.
10. Shipley WU, Kaufman DS, Heney NM et al: An update of combined modality therapy for patients with muscle invading bladder cancer using selective bladder preservation or cystectomy. J Urol 162: 445-451, 1999.
11. Sauer R, Birkenhake S, Kuhn R et al: Efficacy of radiochemotherapy with platin derivatives compared to radiotherapy alone in organ sparing treatment of bladder cancer. Int J Radiat Biol Phys 40: 121-7, 1998.
12. Rodel C, Dunst J, Grabenbauer GG et al: Radiotherapy is an effective treatment for high risk T1 bladder cancer. Strahlenther Onkol 177: 82-88, 2000.
13. AJJC Cancer Staging Manual (ed 5). Philadelphia, PA, Lippicott-Raven, pp. 241, 1997.
14. Sylvester RJ, van der Meijden APM and Lamm DL: Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials. J Urol 168: 1964-1970, 2002.
15. Lamm DL, Blumenstein BA, Crissman JD et al: Maintenance bacillus Calmette-Guerin for recurrent Ta, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group study. J Urol 763: 1124-1129, 2000.
16. Gohji K, Nomi M, Okamoto M et al: Conservative therapy for stage T1b, grade 3 transitional cell carcinoma of the bladder. Urology 53: 308-313, 1999.
17. Iori F, di Seri M, de Nunzio C et al: Long term maintenance bacillus Calmette-Guerin therapy in high-grade superficial bladder cancer. Urology 59: 414-418, 2002.
18. Baniel J, Grauss D, Engelstein D et al: Intravesical bacillus Calmette-Guerin treatment for stage T1 grade 3 transitional cell carcinoma of the bladder. Urology 52: 785-789, 1998.
19. Serretta V, Piazza S, Pavone C et al: Results of conservative treatment (transurethral resection plus adjuvant intravesical chemotherapy) in patients with primary T1, G3 transitional cell carcinoma of the bladder. Urology 47: 647-651, 1996.
20. Brake M, Loertzer H, Horsch R et al: Recurrence and progression of stage T1, grade 3 transitional cell carcinoma of the bladder following intravesical immunotherapy with bacillus Calmette-Guerin. J Urol 163: 1697-1701, 2000.
21. Patard JJ, Moudouni S, Saint F et al: Tumor progression and survival in patients with T1G3 bladder tumors: multicentric retrospective study comparing 94 patients treated during 17 years. Urology 58: 551-556, 2001.
22. Shahin O, Thalmann GN, Rentsch C et al: A retrospective analysis of 153 patients treated with or without intravesical bacillus Calmette-Guerin for primary stage T1 grade 3 bladder cancer: recurrence, progression and survival. J Urol 169: 96-100, 2003.
23. Zhang GK, Ute ET, Sharer WC et al: Reassessment of conservative management for stage T1N0M0 transitional cell carcinoma of the bladder. J Urol 155: 1907-9, 1996.
24. Herr HW: Tumor progression and survival in patients with T1G3 bladder tumors: 15 year outcome. Br J Urol 80: 762-765, 1997.
25. van der Meijden APM, Sylvester R, Collette L et al: The role and impact of pathology review on stage and grade assessment of stages Ta and T1 bladder tumors: a combined analysis of 5 European Organization for Research and Treatment of Cancer trials. J Urol 164: 1533-1537, 2000.
26. Mulders PF, Hoekstra WJ, Heybrock RP, et al: Prognosis and treatment of T1G3 bladder tumors. A prognostic factor analysis of 121 patients. Dutch South Eastern Bladder Cancer Study Group. Eur J Cancer 30A: 914-917, 1994.
27. Smith JA, Whitemore WF Jr: Regional lymph node metastasis from bladder cancer. J Urol 126: 591-593, 198.